Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature

Deguchi, Shoichi; Mitsuya, Koichi; Nakasu, Yoko; Hayashi, Nakamasa; Katagiri, Hirohisa; Murata, Hideki; Wasa, Junji; Takahashi, Mitsuru; Endo, Masahiro

期刊名称Investigational New Drugs
作者Deguchi, Shoichi; Mitsuya, Koichi; Nakasu, Yoko; Hayashi, Nakamasa; Katagiri, Hirohisa; Murata, Hideki; Wasa, Junji; Takahashi, Mitsuru; Endo, Masahiro
印刷ISSN0167-6997
电子ISSN1573-0646
文件大小474.23KB
发表时间2017-10-25
DOI10.1007/s10637-017-0521-5

发现好书期刊，享受阅读乐趣

Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature